Research Output per year
Research Output 1996 2019
Fludeoxyglucose F 18 PET/Computed Tomography Evaluation of Therapeutic Response in Multiple Myeloma
Kumar, S. K., Glazebrook, K. N. & Broski, S., Jan 1 2019, In : PET Clinics.Research output: Contribution to journal › Review article
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
Hillengass, J., Usmani, S., Rajkumar, S. V., Durie, B. G. M., Mateos, M. V., Lonial, S., Joao, C., Anderson, K. C., García-Sanz, R., Serra, E. R., Du, J., van de Donk, N., Berdeja, J. G., Terpos, E., Zamagni, E., Kyle, R. A., San Miguel, J., Goldschmidt, H., Giralt, S., Kumar, S. K. & 15 others, , Jun 1 2019, In : The Lancet Oncology. 20, 6, p. e302-e312Research output: Contribution to journal › Review article
Pros and cons of frontline autologous transplant in multiple myeloma: The debate over timing
Kumar, S. K., Buadi, F. K. & Rajkumar, S. V., Feb 14 2019, In : Blood. 133, 7, p. 652-659 8 p.Research output: Contribution to journal › Review article
Targeted management strategies in multiple myeloma
Kumar, S. K., Jan 1 2019, In : Cancer Journal (United States). 25, 1, p. 59-64 6 p.Research output: Contribution to journal › Review article
Treatment of multiple myeloma: ASCO and CCO joint clinical practice guideline
Mikhael, J. R., Ismaila, N., Cheung, M. C., Costello, C., Dhodapkar, M. V., Kumar, S. K., Lacy, M., Lipe, B., Little, R. F., Nikonova, A., Omel, J., Peswani, N., Prica, A., Raje, N., Seth, R., Vesole, D. H., Walker, I., Whitley, A., Wildes, T. M., Wong, S. W. & 1 others, , Jan 1 2019, In : Journal of Clinical Oncology. 37, 14, p. 1228-1263 36 p.Research output: Contribution to journal › Review article
Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting
Richardson, P. G., San Miguel, J. F., Moreau, P., Hajek, R., Dimopoulos, M. A., Laubach, J. P., Palumbo, A., Luptakova, K., Romanus, D., Skacel, T., Kumar, S. K. & Anderson, K. C., Nov 1 2018, In : Blood Cancer Journal. 8, 11, 109.Research output: Contribution to journal › Review article
Management of relapsed and refractory multiple myeloma: Novel agents, antibodies, immunotherapies and beyond
Chim, C. S., Kumar, S. K., Orlowski, R. Z., Cook, G., Richardson, P. G., Gertz, M., Giralt, S., Mateos, M. V., Leleu, X. & Anderson, K. C., Feb 1 2018, In : Leukemia. 32, 2, p. 252-262 11 p.Research output: Contribution to journal › Review article
Multiple Myeloma, version 3.2018: Featured updates to the NCCN guidelines
Kumar, S. K., Callander, N. S., Alsina, M., Atanackovic, D., Biermann, J. S., Castillo, J., Chandler, J. C., Costello, C., Faiman, M., Fung, H. C., Godby, K., Hofmeister, C., Holmberg, L., Holstein, S., Huff, C. A., Kang, Y., Kassim, A., Liedtke, M., Malek, E., Martin, T. & 10 others, , Jan 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 1, p. 11-20 10 p.Research output: Contribution to journal › Review article
New developments in the management of relapsed/refractory multiple myeloma – The role of ixazomib
Richardson, P. G., Kumar, S. K., Laubach, J. P., Paba-Prada, C., Gupta, N., Berg, D., van de Velde, H. & Moreau, P., Aug 22 2017, In : Journal of Blood Medicine. 8, p. 107-121 15 p.Research output: Contribution to journal › Review article
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group
Cavo, M., Terpos, E., Nanni, C., Moreau, P., Lentzsch, S., Zweegman, S., Hillengass, J., Engelhardt, M., Usmani, S. Z., Vesole, D. H., San-Miguel, J., Kumar, S. K., Richardson, P. G., Mikhael, J. R., da Costa, F. L., Dimopoulos, M. A., Zingaretti, C., Abildgaard, N., Goldschmidt, H., Orlowski, R. Z. & 8 others, , Apr 1 2017, In : The Lancet Oncology. 18, 4, p. e206-e217Research output: Contribution to journal › Review article
Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy
Dingli, D. M., Ailawadhi, S., Bergsagel, P. L., Buadi, F. K., Dispenzieri, A., Fonseca, R., Gertz, M., Gonsalves, W., Hayman, S. R., Kapoor, P., Kourelis, T., Kumar, S. K., Kyle, R. A., Lacy, M., Leung, N., Lin, Y., Lust, J. A., Mikhael, J. R., Reeder, C. B., Roy, V. & 7 others, , Apr 1 2017, In : Mayo Clinic Proceedings. 92, 4, p. 578-598 21 p.Research output: Contribution to journal › Review article
Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
Tandon, N., Ramakrishna, V. & Kumar, S. K., May 6 2016, In : Clinical Pharmacology: Advances and Applications. 8, p. 35-44 10 p.Research output: Contribution to journal › Review article
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Kumar, S. K., Paiva, B., Anderson, K. C., Durie, B., Landgren, O., Moreau, P., Munshi, N., Lonial, S., Bladé, J., Mateos, M. V., Dimopoulos, M., Kastritis, E., Boccadoro, M., Orlowski, R., Goldschmidt, H., Spencer, A., Hou, J., Chng, W. J., Usmani, S. Z., Zamagni, E. & 20 others, , Aug 1 2016, In : The Lancet Oncology. 17, 8, p. e328-e346Research output: Contribution to journal › Review article
New investigational drugs with single-agent activity in multiple myeloma
Rajan, A. M. & Kumar, S. K., Jul 29 2016, In : Blood Cancer Journal. 6, 7, p. e451Research output: Contribution to journal › Review article